1-3 of 3
Anshul Bamrolia, MD
Close
Sort by
Journal Articles

Pegylated Liposomal Doxorubicin (PLD), Vincristine and Reduced-Dose Dexamethasone (DVd) in the Treatment of Predominantly African American Population with Multiple Myeloma.

Anshul Bamrolia, MD, Ahmad Jajeh, MD, R. Catchatourian, MD, David Osafo, MD, Deimante Tamkus, MD, Neelesh Sharma, MD, Ghassan Zalzaleh, MD, Sunita Nathan, MD, Perry Menini, MD
Journal: Blood
Blood (2006) 108 (11): 5105.
https://doi.org/10.1182/blood.V108.11.5105.5105
Published: 2006
Journal Articles

Presentation Characteristics, Risk Profiles and Long-Term Outcomes in a Public Health System, Minority Patient Population with Chronic Lymphocytic Leukemia.

Sunita Nathan, MD, Olusola Ogundipe, MD, Perry Menini, DO, Anshul Bamrolia, MD, Decebal S. Griza, MD, Tracy Smiley, RN, Bhuvaneswari Subramanian, MD, Ahmad Jajeh, MD, Margaret Clare Telfer, MD, R. Catchatourian, MD
Journal: Blood
Blood (2006) 108 (11): 4956.
https://doi.org/10.1182/blood.V108.11.4956.4956
Published: 2006
Journal Articles

Pegylated Liposomal Doxorubicin (PLD), Vincristine and Reduced-Dose Dexamethasone (DVd) in the Treatment of a Predominantly African American Population with Multiple Myeloma.

Ahmad Jajeh, MD, MPH, Rosalind Catchatourian, MD, David Osafo, MD, Deimante Tamkus, MD, Ghassan Zalzaleh, MD, Anshul Bamrolia, MD
Journal: Blood
Blood (2005) 106 (11): 2573.
https://doi.org/10.1182/blood.V106.11.2573.2573
Published: 2005